Evidence map›Paper›PMID 39810391›Full record

ArticleSubstance use & misuse2025

"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 Pandemic.

Elizabeth J Austin, Elsa S Briggs, Maria A Corcorran, Jessica Chen, Nicky Cotta, Czarina N Behrends, Stephanie M Prohaska, Paul A LaKosky, Shashi N Kapadia, David C Perlman and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Substance use & misuse, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elizabeth J AustinDepartment of Health Systems and Population Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-4221-1362
Elsa S BriggsDepartment of Health Systems and Population Health, University of Washington, Seattle, Washington, USA.
Maria A CorcorranDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-4935-5166
Jessica ChenDepartment of Health Systems and Population Health, University of Washington, Seattle, Washington, USA.
Nicky CottaDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Czarina N BehrendsDepartment of Population Health Sciences, Weill Cornell Medical College, New York, New York, USA.
Stephanie M ProhaskaDave Purchase Project, North American Syringe Exchange Network, Tacoma, Washington, USA.
Paul A LaKoskyDave Purchase Project, North American Syringe Exchange Network, Tacoma, Washington, USA.
Shashi N KapadiaDepartment of Population Health Sciences, Weill Cornell Medical College, New York, New York, USA.
David C PerlmanCenter for Drug Use and HIV Research, School of Global Public Health, New York University, New York, New York, USA.
Bruce R SchackmanDepartment of Population Health Sciences, Weill Cornell Medical College, New York, New York, USA.
Don C Des JarlaisSchool of Global Public Health, New York University, New York, New York, USA.ORCID 0000-0002-0157-8168
Emily C WilliamsDepartment of Health Systems and Population Health, University of Washington, Seattle, Washington, USA.
Sara N GlickDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yuhua Bao · 2015 to 2026
$20.7M
Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment ProgramsR01DA027379 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHACKMAN, BRUCE R · 2009 to 2021
$5.3M
Integrated Care for Hepatitis C: Current Uptake & Impact on Future TreatmentK01DA048172 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI KAPADIA, SHASHI · 2019 to 2023
$948k
NIAID NIH HHS P30 AI027757NIDA NIH HHS K01 DA048172NIDA NIH HHS P30 DA011041NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA027379
6 · The paper itself

Abstract

Syringe services programs (SSPs) provide critical evidence-based public health services that decrease harms from drug use for people who use drugs (PWUD). Many SSPs have experienced significant and evolving COVID-19-related disruptions. We aimed to characterize the impacts of COVID-19 on SSP operations in the United States approximately two years into the pandemic. Participating sites, selected from a national sample of SSPs, completed a semi-structured interview Twenty-five SSPs completed the interview and survey between April - June 2022. Triangulation of qualitative and quantitative data characterized the dynamic ways that demand for SSP services has evolved throughout the pandemic, and how approaches to care delivery have increased in flexibility and participant-centeredness. However, SSPs expressed worry about longer-term barriers to program participant and staff engagement, and a mismatch between available programmatic resources and the "new normal" of service delivery needs. The COVID-19 pandemic has had lasting impacts on multiple facets of syringe service delivery. While SSPs consistently meet barriers with ingenuity, greater programmatic and staff support is needed to ensure SSPs can continue to meet the changing public health needs for PWUD.

Indexed as

COVID-19Needle-Exchange ProgramsSubstance Abuse, IntravenousHumansSARS-CoV-2United StatesCOVID-19harm reductionSyringe services programs

Identifiers

PMID39810391
PMCPMC11870795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.